Burden of Illness in Geographic Atrophy: A Study of Vision-Related Quality of Life and Health Care Resource Use

Praveen J Patel,1 Focke Ziemssen,2 Eugene Ng,3 Anushini Muthutantri,4 David Silverman,5 Elizabeth A Tschosik,6 Ronald A Cantrell6 1NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, and University College London Institute of Ophthalmology, London, UK; 2University of Tue...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Patel PJ, Ziemssen F, Ng E, Muthutantri A, Silverman D, Tschosik EA, Cantrell RA
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/4ce1a3a2cc63471795d1ac6e0127c9e6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4ce1a3a2cc63471795d1ac6e0127c9e6
record_format dspace
spelling oai:doaj.org-article:4ce1a3a2cc63471795d1ac6e0127c9e62021-12-02T09:39:56ZBurden of Illness in Geographic Atrophy: A Study of Vision-Related Quality of Life and Health Care Resource Use1177-5483https://doaj.org/article/4ce1a3a2cc63471795d1ac6e0127c9e62020-01-01T00:00:00Zhttps://www.dovepress.com/burden-of-illness-in-geographic-atrophy-a-study-of-vision-related-qual-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Praveen J Patel,1 Focke Ziemssen,2 Eugene Ng,3 Anushini Muthutantri,4 David Silverman,5 Elizabeth A Tschosik,6 Ronald A Cantrell6 1NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, and University College London Institute of Ophthalmology, London, UK; 2University of Tuebingen, Tuebingen, Germany; 3Institute of Eye Surgery, UPMC Whitfield and Waterford Institute of Technology, Waterford, Ireland; 4IQVIA, London, UK; 5Roche Products Limited, Welwyn Garden City, Hertfordshire, UK; 6Genentech, Inc., A Member of the Roche Group, South San Francisco, CA, USACorrespondence: David SilvermanOphthalmology, Roche Products Limited, 6 Falcon Way, Shire Park, Welwyn Garden City AL7 1TW, UKTel +44 1707 36 6394Email david.silverman@roche.comPurpose: To gain comprehensive information on the burden of illness due to geographic atrophy (GA).Methods: This cross-sectional study with a retrospective chart review involved patients aged ≥70 years with physician-confirmed bilateral symptomatic GA due to age-related macular degeneration (GA group), as well as patients of similar age with no ophthalmic condition that in the opinion of the investigator affected visual function (non-GA group). Data relating to patients’ current disease status and sociodemographics were self-reported on patient questionnaires at study entry and extracted from patient charts. Historical data on health care resource utilization (HCRU) were also collected via patient questionnaires and retrospective chart review (GA group only). Overall vision-related functioning and quality of life (QoL) were compared between the GA and non-GA groups using the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) composite and subscales, and change in vision over the past year was assessed using the Global Rating of Change Scale.Results: Vision-related functioning and QoL were poorer in patients with vs without GA (n=137 vs 52), as demonstrated by significantly lower NEI-VFQ-25 composite score (mean, 53.1 vs 84.5 points, respectively; P<0.001), as well as lower subscale scores for near activities, distance activities, dependency, driving, social functioning, mental health, role difficulties, color vision, and peripheral vision. Substantially more patients with GA than without GA reported worsening in vision over the past year (82% vs 25%, respectively; odds ratio, 13.55; P<0.001). In the GA group, associated mean annual costs for direct ophthalmological resource use per patient amounted to €1772 (mostly for tests/procedures), and for indirect ophthalmological resource use, €410 (mostly for general practitioner visits).Conclusion: Patients with GA experience a poorer level of vision-related function and QoL than their peers, especially in relation to driving. GA is also associated with notable HCRU/associated costs, mostly direct costs attributed to diagnostic tests/procedures.Keywords: burden of illness, geographic atrophy, vision-related quality of life, health care resource utilization, visual function, health care costsPatel PJZiemssen FNg EMuthutantri ASilverman DTschosik EACantrell RADove Medical Pressarticleburden of illnessgeographic atrophyvision-related quality of lifehealth care resource utilizationvisual functionhealth care costsOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 14, Pp 15-28 (2020)
institution DOAJ
collection DOAJ
language EN
topic burden of illness
geographic atrophy
vision-related quality of life
health care resource utilization
visual function
health care costs
Ophthalmology
RE1-994
spellingShingle burden of illness
geographic atrophy
vision-related quality of life
health care resource utilization
visual function
health care costs
Ophthalmology
RE1-994
Patel PJ
Ziemssen F
Ng E
Muthutantri A
Silverman D
Tschosik EA
Cantrell RA
Burden of Illness in Geographic Atrophy: A Study of Vision-Related Quality of Life and Health Care Resource Use
description Praveen J Patel,1 Focke Ziemssen,2 Eugene Ng,3 Anushini Muthutantri,4 David Silverman,5 Elizabeth A Tschosik,6 Ronald A Cantrell6 1NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, and University College London Institute of Ophthalmology, London, UK; 2University of Tuebingen, Tuebingen, Germany; 3Institute of Eye Surgery, UPMC Whitfield and Waterford Institute of Technology, Waterford, Ireland; 4IQVIA, London, UK; 5Roche Products Limited, Welwyn Garden City, Hertfordshire, UK; 6Genentech, Inc., A Member of the Roche Group, South San Francisco, CA, USACorrespondence: David SilvermanOphthalmology, Roche Products Limited, 6 Falcon Way, Shire Park, Welwyn Garden City AL7 1TW, UKTel +44 1707 36 6394Email david.silverman@roche.comPurpose: To gain comprehensive information on the burden of illness due to geographic atrophy (GA).Methods: This cross-sectional study with a retrospective chart review involved patients aged ≥70 years with physician-confirmed bilateral symptomatic GA due to age-related macular degeneration (GA group), as well as patients of similar age with no ophthalmic condition that in the opinion of the investigator affected visual function (non-GA group). Data relating to patients’ current disease status and sociodemographics were self-reported on patient questionnaires at study entry and extracted from patient charts. Historical data on health care resource utilization (HCRU) were also collected via patient questionnaires and retrospective chart review (GA group only). Overall vision-related functioning and quality of life (QoL) were compared between the GA and non-GA groups using the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) composite and subscales, and change in vision over the past year was assessed using the Global Rating of Change Scale.Results: Vision-related functioning and QoL were poorer in patients with vs without GA (n=137 vs 52), as demonstrated by significantly lower NEI-VFQ-25 composite score (mean, 53.1 vs 84.5 points, respectively; P<0.001), as well as lower subscale scores for near activities, distance activities, dependency, driving, social functioning, mental health, role difficulties, color vision, and peripheral vision. Substantially more patients with GA than without GA reported worsening in vision over the past year (82% vs 25%, respectively; odds ratio, 13.55; P<0.001). In the GA group, associated mean annual costs for direct ophthalmological resource use per patient amounted to €1772 (mostly for tests/procedures), and for indirect ophthalmological resource use, €410 (mostly for general practitioner visits).Conclusion: Patients with GA experience a poorer level of vision-related function and QoL than their peers, especially in relation to driving. GA is also associated with notable HCRU/associated costs, mostly direct costs attributed to diagnostic tests/procedures.Keywords: burden of illness, geographic atrophy, vision-related quality of life, health care resource utilization, visual function, health care costs
format article
author Patel PJ
Ziemssen F
Ng E
Muthutantri A
Silverman D
Tschosik EA
Cantrell RA
author_facet Patel PJ
Ziemssen F
Ng E
Muthutantri A
Silverman D
Tschosik EA
Cantrell RA
author_sort Patel PJ
title Burden of Illness in Geographic Atrophy: A Study of Vision-Related Quality of Life and Health Care Resource Use
title_short Burden of Illness in Geographic Atrophy: A Study of Vision-Related Quality of Life and Health Care Resource Use
title_full Burden of Illness in Geographic Atrophy: A Study of Vision-Related Quality of Life and Health Care Resource Use
title_fullStr Burden of Illness in Geographic Atrophy: A Study of Vision-Related Quality of Life and Health Care Resource Use
title_full_unstemmed Burden of Illness in Geographic Atrophy: A Study of Vision-Related Quality of Life and Health Care Resource Use
title_sort burden of illness in geographic atrophy: a study of vision-related quality of life and health care resource use
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/4ce1a3a2cc63471795d1ac6e0127c9e6
work_keys_str_mv AT patelpj burdenofillnessingeographicatrophyastudyofvisionrelatedqualityoflifeandhealthcareresourceuse
AT ziemssenf burdenofillnessingeographicatrophyastudyofvisionrelatedqualityoflifeandhealthcareresourceuse
AT nge burdenofillnessingeographicatrophyastudyofvisionrelatedqualityoflifeandhealthcareresourceuse
AT muthutantria burdenofillnessingeographicatrophyastudyofvisionrelatedqualityoflifeandhealthcareresourceuse
AT silvermand burdenofillnessingeographicatrophyastudyofvisionrelatedqualityoflifeandhealthcareresourceuse
AT tschosikea burdenofillnessingeographicatrophyastudyofvisionrelatedqualityoflifeandhealthcareresourceuse
AT cantrellra burdenofillnessingeographicatrophyastudyofvisionrelatedqualityoflifeandhealthcareresourceuse
_version_ 1718398063846883328